5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies
Accreditation: 10.25 ABIM MOC II | 10.25 Nursing Contact Hours | 10.25 ACPE Pharmacy | 10.25 AMA PRA Category 1 Credit™
Venue: InterContinental San Francisco, 888 Howard Street, San Francisco, CA, United States
Official conference page for 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies . https://binaytara.org/projects/conferences/5th-binaytara-precision-oncology-summit-redefining-cancer-treatment-with-molecular-targeted-strategies
About 5th Binaytara Precision Oncology Summit: Redefining Cancer Treatment with Molecular Targeted Strategies


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Our Agenda
Day 1: Friday, October 24th, 2025
All timings are in Pacific Time (PDT, GMT-07:00) time.
Session Chair: Sylvia K. Plevritis, PhD
10:00 AM - 10:20 AM
Artificial Intelligence in Precision Oncology: Predicting Outcomes in Cancer – Haruka Itakura, MD, PhD
10:20 AM - 10:40 AM
Multi-modal AI for Cancer Biology and Clinical Decision Support – Sylvia K. Plevritis, PhD
10:40 AM - 11:00 AM
Panel Discussion – Haruka Itakura, MD, PhD; Sylvia K. Plevritis, PhD
Session Chair: Marianne Dubard-Gault, MD
11:00 AM - 11:15 AM
Clinico-genomic Characterization of PALB2-Mutated Pancreatic Adenocarcinoma. – Jonathan Lee, MD
11:15 AM - 11:30 AM
Ph-like ALL Exhibits Unique Hematological Features with CD36 Overexpression: A Diagnostic and Prognostic Analysis of 1,021 Indian Patients. – Dikshat Gopal Gupta, PhD
11:30 AM - 11:45 AM
Race/ethnicity associated clinico-genomic, socioeconomic, and environmental predictors in metastatic non-small cell lung cancer (mNSCLC) treated with immunotherapy. – Nirosha Perera King, MD
11:45 AM - 12:00 PM
Utilization and Timing of First Tumor Next-generation Sequencing Testing (NGS) in Patients with Five Most Common Cancers in the USA. – Zeynep Irem Ozay, MD
Session Chair: Pamela Munster, MD; Mark Daniel Pegram, MD
01:00 PM - 01:15 PM
RTK inhibitors in NSCLC – Nathaniel James Myall, MD
01:15 PM - 01:30 PM
PI3K Pathway – Pamela Munster, MD
01:30 PM - 01:45 PM
RAS/RAF in Melanoma – Adil Daud, MD
01:45 PM - 02:00 PM
Q & A/Discussion
Session Chair: Mark Daniel Pegram, MD
02:00 PM - 02:20 PM
ESR1 Mutation – Milana v Dolezal, MD
02:20 PM - 02:40 PM
MTAP Deletion – Shruti Rajesh Patel, MD
02:40 PM - 03:00 PM
KRAS G12C Mutation – Surbhi Singhal, MD
03:00 PM - 03:20 PM
EZH2 Mutation in Sarcoma – Varun Monga, MD, MBBS
Session Chair: Mamta Parikh, MD
03:30 PM - 04:00 PM
Panel Discussion – Nicholas Mitsiades, MD; Jason N Rosenbaum, MD; Ibrahim Halil Sahin, MD
Session Chair: Henry T Greely, JD
04:00 PM - 04:15 PM
Ethics in Precision Oncology – Henry T Greely, JD
04:15 PM - 04:45 PM
Panel Discussion – Sachdev P Thomas, MD; Meera Ragavan, MD; Alborz Alali, MD
Session Chair: Pamela Munster, MD
04:45 PM - 05:05 PM
Development of Personalized Cancer Vaccines and Immunotherapy – Chen Fu, MD
05:05 PM - 05:30 PM
Panel Discussion – Adil Daud, MD; Chen Fu, MD
Day 2: Saturday, October 25th, 2025
Venue and map
Accreditations and continuing education
Acknowledgement of Commercial Support
This activity is supported with Independent Medical Education grants from Novartis, Merck, and Gilead.